Global Protein-Bound Paclitaxel (Abraxane) Market Projected to Reach USD 4.3 Billion by 2032, Driven by Advancements in Oncology Therapies and Rising Cancer Prevalence
The global Protein-Bound Paclitaxel (Abraxane) Market is experiencing significant growth, propelled by the increasing incidence of cancer worldwide and the rising adoption of targeted chemotherapy treatments. Abraxane, a novel formulation of paclitaxel bound to albumin nanoparticles, offers improved solubility and reduced hypersensitivity reactions compared to traditional solvent-based paclitaxel, making it a preferred choice in oncology therapeutics. Market … Read more